Infections caused by ESBL producing bacteria can complicate cancer treatment in several ways. These infections can lead to delays in chemotherapy or surgery due to the need to resolve the infection first. Additionally, the limited options for effective antibiotics can result in prolonged hospital stays and increased healthcare costs. In severe cases, these infections can be life-threatening, especially for patients with already weakened health.
